CenterStar Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

CenterStar Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$320K	Buy	+5,284	New	+$308K	0.04%	391
2025 Q1	–	Sell	-11,315	Closed	-$660K	–	337
2024 Q4	$640K	Buy	+11,315	New	+$632K	0.22%	91
2023 Q3	–	Sell	-7,603	Closed	-$486K	–	332
2023 Q2	$486K	Buy	+7,603	New	+$510K	0.05%	212
2021 Q1	–	Hold	0	–	–	–	289
2020 Q4	–	Hold	0	–	–	–	431
2020 Q2	–	Hold	0	–	–	–	557
2020 Q1	–	Hold	0	–	–	–	91
2019 Q4	–	Hold	0	–	–	–	398
2018 Q4	–	Hold	0	–	–	–	4

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CenterStar Asset Management's BMY Position: Q1 2026 in Review

CenterStar Asset Management opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 5,284 shares worth $320K. The stake represents 0.04% of the portfolio and ranks #391 among its holdings. This is a return to the name: CenterStar Asset Management previously reported a position in BMY as recently as Q4 2024.

CenterStar Asset Management first reported a position in BMY in Q2 2023 and has held it in 3 quarters since. The position peaked at $640K in Q4 2024. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

CenterStar Asset Management held 5,284 shares of Bristol-Myers Squibb worth $320K as of Q1 2026.
Bristol-Myers Squibb was a new CenterStar Asset Management position in Q1 2026.
Bristol-Myers Squibb made up 0.04% of CenterStar Asset Management's portfolio in Q1 2026, its #391 holding.
CenterStar Asset Management first reported a position in Bristol-Myers Squibb in Q2 2023 and has held it in 3 quarters since.
CenterStar Asset Management's Bristol-Myers Squibb position peaked at $640K in Q4 2024.
2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on CenterStar Asset Management's 13F filing for Q1 2026, filed 1 May 2026.